Ester Baiget, president and CEO of Novozymes. [Photo provided to China Daily]

The company is also committed to strengthening its collaboration with Chinese industrial players and expanding its research and development efforts locally. As a strong growth engine for both global and local markets, its R&D center in China has been operating for 25 years and has been collaborating with various domestic universities.

Meanwhile, with the accelerated implementation of China's dual carbon goals — peaking carbon dioxide emissions by 2030 and achieving carbon neutrality by 2060 — Novozymes said it is thrilled about China's pledge, as biotech can provide solutions to a variety of sectors and contribute to the many dimensions and objectives of China's carbon neutrality plan.

As China's top policymakers have pledged efforts to attract more foreign capital and promote further opening-up, it is offering new opportunities for the growth of more multinationals.

"China's growth potential is being released at an accelerated pace this year. Foreign companies are actively tapping market demand and speeding up their investments. This has further reflected their confidence in growing business in the country," said Bai Ming, deputy director of international market research at the Chinese Academy of International Trade and Economic Cooperation in Beijing.

Novozymes said it is optimistic about the potential benefit such moves can bring to foreign investors.

"We are pleased to see the Chinese government's recent efforts to optimize the investment environment for foreign investors and encourage investment in new energy, green and low-carbon innovation and demonstration," Baiget said.